Motif prediction of abemaciclib in a breast cancer cell line using ChIP-Seq data analysis. Biomedical Research and Therapy, [S. l.], v. 9, n. 3, p. 4971–4985, 2022. DOI: 10.15419/bmrat.v9i3.732. Disponível em: https://preservation.bmrat.org/index.php/BMRAT/article/view/732.. Acesso em: 15 nov. 2024.